Sleep Apnea Treatment Devices Market - What will be the Short-term Impact of Coronavirus?

The global sleep apnea treatment devices market size is set to touch USD 8.97 billion by 2026, exhibiting a CAGR of 8.2% during the forecast period. Steadily climbing demand for sleep apnea devices, stemming from a consistent spread in the prevalence of sleep apnea, will be a major growth driver for this market, shares Fortune Business Insights™ in its new report, titled “Sleep Apnea Treatment Devices Market Size, Share & Industry Analysis, By Device Type (Positive Airway Pressure (PAP) Devices, Oral Appliances, Masks & Accessories, and Others), By End User (Sleep Laboratories & Clinics, and Homecare & Other Settings), and Regional Forecast, 2019-2026.

For more information in the analysis of this report, visit:

List of Players Covered in the Report:

  • Braebon Medical Corporation
  • Glidewell
  • Oventus
  • Fisher & Paykel Healthcare Limited
  • ResMed
  • DeVilbiss Healthcare
  • BMC Medical Co., Ltd.
  • SomnoMed
  • Koninklijke Philips N.V.

A study published in the medical journal Lancet in 2019 found that nearly 1 billion people worldwide suffer from Obstructive Sleep Apnea (OSA). Regionally, too, the statistics conform to the global trends. For instance, the European Respiratory Society estimates that 13% to 32% of the geriatric population in Europe suffer from sleep apnea. As a result, the demand for sleep apnea treatment is escalating and driving the sleep apnea treatment devices market trends. Furthermore, the incidence of OSA is spiking owing to the rising prevalence of obesity, the most common cause for interrupted sleep, which according to the World Health Organization, presently affects close to 650 million adults worldwide.

Request a Sample Copy of the Research Report:

According to the report, the value of the market stood at USD 4.82 billion in 2018. The report further contains:

  • Thorough analysis of the factors and trends driving and restraining the market;
  • Comprehensive research into the regional and competitive dynamics of the market;
  • Detailed segmentation of the market and in-depth evaluation of the individual market segments; and
  • Precise computation of market figures and values.

Regional Analysis

Availability of Advanced Treatment Options to Propel the Market in North America

With a market size of USD 2.35 billion in 2018, North America is poised to dominate the sleep apnea treatment devices market share during the forecast period. The key factors augmenting this regional market include wide availability and high adoption of advanced products, along with growing prevalence of sleep disorders among the populace. In addition to this, supportive health insurance and reimbursement policies are further fueling the uptake of these devices in the region.

In Asia-Pacific, the major driving force for the market is the rising demand for sleep apnea therapies in Japan and the presence of a large, underpenetrated market in the rest of the region. These factors are expected to aid Asia-Pacific to register a considerable CAGR in the upcoming years.